Joint Plus
Max Drive Nutrition's Joint Plus is a combination supplement designed to support joint health, falling under the Longevity & NAD+ category. This product contains 8 ingredients, with a transparent label indicating all dosages. Key ingredients include Glucosamine Sulfate at 1500mg, Boswellia Extract at 200mg, and Chondroitin Sulfate at 150mg. However, based on current research, none of the ingredients are present at commonly recognized clinical dosages for their intended effects, resulting in an N+ Score of 64 and a 'D' grade. The formula's ingredient adequacy and completeness scores are both low, suggesting potential underdosing for several components. This product may be considered by individuals seeking a general joint support formula, though higher doses of key ingredients might be beneficial for more pronounced effects.
About This Product
Joint Plus by Max Drive Nutrition is a longevity & nad+ supplement containing 8 active ingredients. It has earned an N+ Score of 64/100 (Grade D).
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (8 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Quercetin | 25.000 mg | N/A |
| Bromelain | 25.000 mg | N/A |
| Chondroitin Sulfate | 150.000 mg | N/A |
| Glucosamine Sulfate | 1500.000 mg | N/A |
| Boswellia extract | 200.000 mg | N/A |
| MSM | 25.000 mg | N/A |
| Turmeric | 150.000 mg | N/A |
| Methionine | 25.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.